ArticleFrontiers in medicine2023
Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 14 citations in OpenAlex.
- Computed tomography findings and severity scores in Chlamydia psittaci pneumonia: a retrospective study of 69 cases with clinical correlation.BMC infectious diseases · 2026Article
- A novel risk stratification model based on creatine kinase and direct bilirubin for identifying severe Chlamydia psittaci pneumonia: a double-center, hypothesis-generating retrospective cohort study.BMC infectious diseases · 2026Article
- Clinical features and prognostic factors ofFrontiers in medicine · 2026Article
- Clinical Characteristics of 40 Cases ofInfection and drug resistance · 2026Article
- Clinical Characteristics and Machine Learning-Based Severity Classification ofInfection and drug resistance · 2026Article
- Clinical Features and Risk Factors for Severe Disease in 57 Cases ofInfection and drug resistance · 2026Article
- Clinical Characteristics and Outcomes of Carbapenem-Resistant Gram-Negative Bacteria Pneumonia in Immunocompromised ICU Patients: A Retrospective Study.Infection and drug resistance · 2026Article
- Successful azithromycin treatment ofFrontiers in pharmacology · 2026Article
- Clinical characteristics of Chlamydia psittaci pneumonia: a single-center, retrospective study over 5 years.BMC infectious diseases · 2025Article
- Clinical Characteristics and Predicting Disease Severity in Chlamydia psittaci Infection Based on Metagenomic Next-Generation Sequencing.Infection and drug resistance · 2025Article
- Analysis of Clinical Characteristics and Severe Factors of 47 Cases of Psittacosis.Infection and drug resistance · 2025Article
- A case-control study onFrontiers in medicine · 2025Article
- Analysis of Risk Factors for Severe Pneumonia Progression in Chlamydia psittaci Infections: A Retrospective Study.International journal of general medicine · 2025Article
- A case of severe psittacosis pneumonia complicated by splenic infarction.BMC infectious diseases · 2024Article
- Serum C-reactive protein to albumin ratio as a potential risk indicator of pneumonia caused byFrontiers in cellular and infection microbiology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: More and more patients with community-acquired pneumonia have been detected with Methods: In this retrospective study, we included all confirmed cases of Results: We enrolled 55 patients with Conclusion:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.